BioMarin Pharmaceutical Inc. Equity-NMS: BMRN

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$57.33

Open :

$56.92

Today's high :

$57.63

Today's low :

$56.48

52W low :

$52.93

52W high :

$94.85

EPS(TTM): :

3.32

Shares O/S :

192.02 M

Market cap :

10.91 B

What is the share price of BioMarin Pharmaceutical Inc. today?

BioMarin Pharmaceutical Inc. (BMRN) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of BioMarin Pharmaceutical Inc.?

Yes, Indian Investors can invest in the BioMarin Pharmaceutical Inc. (BMRN) Share by opening an international trading account with Angel One.

How can I purchase BioMarin Pharmaceutical Inc. shares in India?

Purchasing BioMarin Pharmaceutical Inc. (BMRN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying BioMarin Pharmaceutical Inc. (BMRN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of BioMarin Pharmaceutical Inc.?

Yes, you can purchase fractional shares of BioMarin Pharmaceutical Inc. (BMRN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of BioMarin Pharmaceutical Inc.?

The market capitalization of BioMarin Pharmaceutical Inc. on January 1, 1970, is $0.

What documents are required to invest in BioMarin Pharmaceutical Inc. stocks?

In order to invest in BioMarin Pharmaceutical Inc. (BMRN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

BioMarin Pharmaceutical Inc. is a global biotechnology company engaged in the development of genetic discovery into medicines that make an impact on the life of each patient. The Company has eight commercial therapies and a clinical and preclinical pipeline. Its commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno-associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Its key clinical programs include Vosoritide, BMN 333, BMN 390, BMN 351, BMN 349, and INZ-701. Its late-stage enzyme replacement therapy, INZ-701, is being developed for the treatment of ENPP1 deficiency.